LAKE ZURICH, Ill.--(BUSINESS WIRE)--Fresenius Kabi announced today the immediate availability in the United States of Adenosine Injection, USP in 60 mg per 20 mL and 90 mg per 30 mL presentations.

November 3 2008--LAKE FOREST, Ill.--(BUSINESS WIRE)--Akorn, Inc. (NASDAQ: AKRX) today announced that the U.S. Food and Drug Administration has granted approval for Akorn's Abbreviated New Drug ...

Adenosine Injection, a pharmacologic stress agent, is indicated as an adjunct to thallium-201 myocardial perfusion scintigraphy in patients unable to exercise adequately. Fresenius Kabi announced the ...

Fresenius Kabi announced the launch of Adenosine Injection, USP, 6mg/2mL and 12mg/4mL, in single-dose Simplist ready-to-administer prefilled syringes. Fresenius Kabi announced the launch of Adenosine ...

Sagent Pharmaceuticals, Inc. SGNT today announced the reintroduction of Adenosine Injection, USP, an antiarrhythmic agent, now in improved prefilled plastic syringes. According to IMS, for the 12 ...

Indian pharmaceutical company Strides Arcolab on Tuesday said it got the United States Food and Drug Administration (FDA) approval to sell an additional package size of Adenosine injection used for ...

Strides Arcolab Limited has informed the Exchange regarding a press release dated January 18, 2011, titled "STRIDES ARCOLAB ANNOUNCES USFDA APPROVAL FOR ADDITIONAL ADENOSINE INJECTION USP". Advisory ...

Astellas currently markets Adenoscan (R) (adenosine injection), the leading pharmacologic stress agent for MPI studies in the United States. Adenoscan is indicated as an adjunct to thallium-201 ...

IRVINE, Calif. Teva Health Systems has introduced its adenosine injection, USP in a pre-filled syringe, the company announced Wednesday. Teva’s adenosine is AP rated to Astellas Pharma’s Adenocard IV ...

Complete portfolio of all commonly used sizes and strengths of Adenosine Injection, USP now available from Fresenius Kabi Fresenius Kabi announced today the immediate availability in the United States ...